Vericel (NASDAQ: VCEL) CLO exercises options and sells 15K shares
Rhea-AI Filing Summary
Vericel Corp Chief Legal Officer Sean C. Flynn exercised options to acquire 15,000 shares of common stock at $16.25 per share and, on the same day, sold 15,000 shares at an average price of $40.21 per share. The sale was executed automatically under a pre-arranged Rule 10b5-1 trading plan adopted on December 2, 2025, indicating it was scheduled in advance. After these transactions, Flynn holds 1,647 common shares directly and 70,000 stock options exercisable at $16.25 per share that are scheduled to expire on November 4, 2029.
Positive
- None.
Negative
- None.
Insights
Routine option exercise-and-sale under a pre-set trading plan.
The filing shows Vericel’s Chief Legal Officer exercising stock options for 15,000 shares at $16.25 and selling the same number at about $40.21. This is a classic exercise-and-sell pattern that converts option value into cash.
The footnotes state the sales were made under a Rule 10b5-1 trading plan adopted on December 2, 2025, meaning trades were pre-scheduled rather than timed opportunistically. After the transactions, he retains 1,647 common shares and 70,000 options exercisable at $16.25 until November 4, 2029.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | -- |
| Exercise | Common Stock | 15,000 | $16.25 | $244K |
| Sale | Common Stock | 15,000 | $40.21 | $603K |
Footnotes (1)
- These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.